Plain-English translation of NCT07593092 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This Phase 1 trial is testing whether two investigational medications called and are safe when used together to treat advanced ovarian cancer. The study will also examine how well this combination works against tumors. Researchers are looking for the right doses of these medications and whether they help people with this condition.
Advanced ovarian cancer is a serious condition, and many people need new treatment options. This medication targets a specific marker found on certain ovarian cancer cells, offering a potentially new way to fight the disease.
You likely qualify if…
You likely don't qualify if…
You would receive the two medications as part of a dose-escalation study, meaning the doses may be adjusted as researchers learn more about safety. You would attend study visits where doctors monitor your health, check your tumor response, and watch for any side effects. The study involves about 90 participants total, and your specific involvement would depend on which dose group you join and how you respond to treatment.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States